ELTX - Latest News
Elicio Therapeutics, Inc. (ELTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $215.7M. Beta to the broader market is 1.12.
The article list below shows the most recent ELTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ELTX Headlines
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com - May 11, 2026
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), the event-driven primary dis
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
globenewswire.com - Apr 30, 2026
BOSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology compan
Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out
seekingalpha.com - Apr 29, 2026
Elicio Therapeutics (ELTX) is approaching a pivotal trial readout for its KRAS peptide vaccine, positioning 2026 as a critical year for KRAS therapies
Elicio Therapeutics Reports Inducement Grants
globenewswire.com - Apr 16, 2026
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology compan
Advancements in Novel Immunotherapeutics in The Oncology Battle
newsfilecorp.com - Mar 24, 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - March 24, 2026) - Investorideas.
How News Affects ELTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ELTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ELTX news questions
- What is the latest ELTX news headline?
- The most recent ELTX headline (May 11, 2026) is "Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ELTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ELTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ELTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.